A minimally invasive treatment for carpal tunnel syndrome provides long-term relief to patients without the use of corticosteroids, according to research presented at the annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December, Chicago, USA).
Boston Scientific has announced that it will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec Scientific, a Chinese medical technology company that offers solutions designed for a variety of interventional procedures.
Delcath Systems announced the publication of a retrospective analysis of patients who underwent a PHP procedure with Chemosat for the treatment of either inoperable intrahepatic cholangiocarcinomas (iCCA) or extrahepatic cholangiocarcinoma (eCCA) with liver metastases.
RF Medical is a Korean thermal ablation system manufacturer and the creator of the Mygen M-3004 generator and specialised electrodes including Myoblate. Both of these products have been cleared by the US Food and Drug Administration (FDA) and are now commercially available in the USA.
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device Regulation (MDR) will be put forward in early 2023.
Cook Medical announces John A Kaufman (Cook Medical, Bloomington, USA) will be joining as its chief medical officer, effective July 2023. With Kaufman’s expertise and new appointment to this position, Cook is taking a significant step in its clinical and product-related goals.
Egg Medical, a medical device company commercialising technologies to reduce scatter radiation exposure during interventional angiographic procedures, has announced that it has achieved CE mark for the EggNest XR radiation protection system.
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedicated business within the Advanced Therapies area of Siemens Healthineers, the company has announced.
The Society of Interventional Radiology (SIR) published a position statement deeming endovascular thrombus removal “an acceptable treatment option in selected patients with acute iliofemoral deep vein thrombosis [DVT].”
RCR president Kath Halliday (Nottingham University Hospitals, Nottingham, UK) gave a presentation to the British Society of Interventional Radiology (BSIR) annual scientific meeting (2–4 November, Glasgow, UK) exploring how new technologies and infrastructural reforms can improve outcomes for patients under IR department care.